UNSPSC 51173217: Calcium pantothenate/danthron/docusate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA209. This VA Drug Class (GA209) classifies this compound as belonging to the group LAXATIVES, OTHER.

UNSPSC 51173217 Calcium pantothenate/danthron/docusate is a Commodity code that does not align with the recent state and local procurement activity it has been tagged with. The three most recent opportunities posted under this code span offender drug testing services, direct-to-manufacturer pharmaceutical distribution pathways, and generic multi-source pharmaceutical supply — none of which involve the specific combination pharmaceutical product (calcium pantothenate/danthron/docusate) the code nominally describes. The mismatch suggests either a taxonomic misclassification in the state and local procurement systems tagging these solicitations, or that the code has been repurposed to capture broader pharmaceutical sourcing and testing activities at the state level without strict alignment to the product code's chemical specification.

The three opportunities show activity across Texas (Collin County Community Supervision and Corrections Department, Texas Health and Human Services Commission) and Minnesota (MMCAP cooperative purchasing on behalf of participating state and local governments including Oregon). Collin County issued RFP 2026-327 on July 9, 2026, for offender specimen collection and drug testing services with a July 23, 2026 response deadline and an estimated contract value of $600,000 over two years with optional renewal through year five; the scope covers staffing, immunoassay screening, LC/MS/MS or GC/MS confirmation, and electronic result reporting for approximately 25,031 annual tests. Texas HHS issued RFI HHS0017013 (posted March 27, 2026, response deadline April 3, 2026) to gather vendor capabilities for direct-to-manufacturer prescription fulfillment outside traditional pharmacy benefit manager and group purchasing organization channels. MMCAP, administered by Minnesota Department of Administration, issued RFP S1070000015802 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers, with contract effectiveness July 1, 2026 and evaluation weighted 75 percent on price competitiveness. The code shows little relevant recent activity aligned to its nominal product scope.